Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Marek, Spaczyński"'
Autor:
Marek Spaczyński, Anna Romała, Magdalena Magnowska, Ewa Nowak-Markwitz, Natalia Iżycka, Joanna Kapoła-Czyż, Jakub Lorek
Publikováno v:
Ginekologia polska. 89(4)
Objectives: Chemotherapy-induced peripheral neuropathy (CIPN) is a common chemotherapy side effect, but its prevention and treatment remains a challenge. Neurotoxicity may lead to dose limitation or even treatment discontinuation, and therefore poten
Autor:
Piotr Dziegiel, Marek Spaczyński, Christopher Kobierzycki, Bartosz Pula, Marzenna Podhorska-Okolow, Maciej Zabel, Ewa Nowak-Markwitz, Krzysztof Latkowski, Witold Kędzia, Aleksandra Piotrowska
Publikováno v:
Anticancer Research. 38
BACKGROUND/AIM It has been shown in many studies that expression of pyruvate kinase (PK) enzyme plays a key role during cellular metabolism. There is evidence that cancer cells manifesting very dynamic proliferation may control their division in vari
Publikováno v:
Polish Gynaecology. 86:419-423
Objectives: Since metformin was reported to decrease overall cancer incidence and mortality and to have antiproliferative and antiinvasive properties, we investigated the impact of metformin intake on survival in endometrial cancer patients. Material
Autor:
Andrzej Frankowski, Magdalena Magnowska, Agnieszka Lemańska, Marek Spaczyński, Ewa Nowak-Markwitz, Paulina Banach
Publikováno v:
Archives of Medical Science. 1:240-252
Vulvar melanoma is an aggressive neoplasm with a poor prognosis. Approximately 25% to 50% of patients survive 5 years [1]. This malignancy is prone to late metastasis, so 5-year survival does not equal cure. The management of recurrent disease contin
Autor:
Marcin Michalak, Piotr Jasiński, Agnieszka Lemańska, Ewa Nowak-Markwitz, Wojciech Warchoł, Emilia Gąsiorowska, Marek Spaczyński
Publikováno v:
Polish Gynaecology. 86:88-93
Objectives: The aim of this study was to assess the sensitivity and specificity of HE4 in detecting and differentiating between types I and II epithelial ovarian cancer (EOC) in comparison with CA125. Material and methods: We measured HE4 and CA125 s
Autor:
Bartosz Pula, Ewa Nowak-Markwitz, Maciej Zabel, Witold Kędzia, Marzenna Podhorska-Okolow, Piotr Dziegiel, Agata Zemla, Marek Spaczyński, Christopher Kobierzycki, Karolina Jablonska
Publikováno v:
International Journal of Molecular Sciences
Volume 15
Issue 12
Pages 23074-23089
International Journal of Molecular Sciences, Vol 15, Iss 12, Pp 23074-23089 (2014)
Volume 15
Issue 12
Pages 23074-23089
International Journal of Molecular Sciences, Vol 15, Iss 12, Pp 23074-23089 (2014)
Ovarian cancer (OC) is the leading cause of death among women with genital tract disorders. Melatonin exhibits oncostatic properties which it may effect through binding to its membrane receptor, MT1. The aim of this study was to determine the express
Autor:
Florence Thomas, Jacek Wysocki, P.V. Suryakiran, Marek Spaczyński, Andrzej Galaj, Tino F. Schwarz, Karin Schulze, Dominique Descamps, Andreas M. Kaufmann
Publikováno v:
BJOG: An International Journal of Obstetrics & Gynaecology. 122:107-118
Objective Evaluation of the long-term HPV-16/18 AS04-adjuvanted vaccine immunogenicity persistence in women. Design Multicentre, open-label, long-term follow-up (NCT00947115) of a primary phase–III study (NCT00196937). Setting Six centres in German
Autor:
Wojciech Rzeszutko, Marek Spaczyński, Andrzej Frankowski, Magdalena Magnowska, Ewa Nowak-Markwitz
Publikováno v:
Archives of Medical Science. 1:237-239
The incidence of endometrial cancer (EC) in the population of young women has been increasing. Total hysterectomy with bilateral salpingo-oophorectomy remains the standard therapy for early endometrial cancer [1]. However, doctor and patient attitude
Autor:
Ewa Nowak-Markwitz, Marek Spaczyński, Antoni Basta, Włodzimierz Sawicki, Przemysław Oszukowski, Jan Kotarski, Janina Markowska, Stefan Sajdak
Publikováno v:
Polish Gynaecology. 86:712-714
Autor:
Ewa, Nowak-Markwitz, Marek, Spaczyński
Publikováno v:
Ginekologia polska. 86(12)
After the discovery of the role human papilloma virus (HPV) plays in the development of cervical cancer we are witnesses to a change in the conception and interpretation of cervical cancer prevention processes. Primary prevention gained a new tool in